Mohammad Reza (Nima) Darbandi | Breast Cancer | Best Researcher Award

Posted on by ScienceFather

Mr. Mohammad Reza (Nima) Darbandi | Breast Cancer | Best Researcher Award

PhD candidate of University of Georgia, United States.

Nima Darbandi is a Ph.D. student in Computer Science at the University of Georgia, where he also serves as a research and teaching assistant. His research focuses on optimizing the llama.cpp framework and developing AI systems for domain detection using DNS logs. Nima has extensive experience in teaching subjects like Discrete Mathematics and Computer Networks. He has held various roles in the industry, including Linux Expert at Parspack Cloud Services, Consultant at Monenco Industry Group, and Chief Technical Officer at HamyarNet ISP. Nima’s research skills encompass AI, computer networks, and system administration, with a strong foundation in Network+, CCNA, and Linux Essentials. His contributions to artificial intelligence and disease treatment highlight his innovative approach and interdisciplinary expertise. He has been recognized with several awards, including the Outstanding Teaching Assistant Award from the University of Georgia.

Professional Profiles:

Education

Nima Darbandi is currently pursuing his Ph.D. in Computer Science at the University of Georgia, Athens, GA, USA, starting in the fall of 2022. He earned his M.S. in Information Technology from the Iran University of Science and Technology, Tehran, IRAN, where he conducted a dissertation titled “A New Method to Estimate QoE for Internet Users” from 2011 to 2015. Before that, he completed his B.S. in Information Technology at Shiraz University of Technology, Shiraz, IRAN, between 2006 and 2010.

Professional Experience

Nima Darbandi has a diverse professional background in both academia and industry. As a Research/Teaching Assistant at the University of Georgia, he worked on llama.cpp framework optimization and AI systems for DNS logs under Dr. Agrawal, Dr. Niu, and Dr. Perdisci from 2022 to 2024, while also teaching Discrete Mathematics and Computer Networks. In the industry, he served as a Linux Expert at Parspack Cloud Services in Tehran from 2021 to 2022, and as a Consultant for Monenco Industry Group from 2020 to 2022, where he developed a Dispatching System on CISCO telephony. Nima held the position of Chief Technical Officer at HamyarNet ISP from 2017 to 2020, overseeing ADSL and P2P wireless Internet services. He founded Puzzle Network Solutions, focusing on network services and devices, from 2014 to 2017, and was a Senior Manager at SabaNet ISP from 2009 to 2014. He also has extensive teaching experience, providing Network+, CCNA, Linux Essentials, and Computer Networking courses across several institutions in Shiraz from 2007 to 2018.

Research Interest

Nima Darbandi’s research interests lie primarily in the fields of computer science, information technology, and artificial intelligence. He is particularly focused on optimizing AI frameworks, such as llama.cpp, and utilizing AI for domain-specific applications like DNS log analysis. His work includes enhancing the quality of experience (QoE) for internet users, which was the subject of his M.S. dissertation. Nima is also interested in developing AI-driven solutions for early diagnosis and precision treatment in healthcare, as evidenced by his publication on AI breakthroughs in breast cancer treatment. Additionally, his research spans into network management, cloud hosting services, and cybersecurity, showcasing a broad interest in both theoretical and applied aspects of computing and technology.

Award and Honors

Nima Darbandi has received several awards and honors throughout his academic and professional career. In 2023, he was honored with the Outstanding Teaching Assistant Award from the University of Georgia, recognizing his excellence in teaching and support for students. In 2016, he received the Best Supporter and Advisor Token of Appreciation from Kavosh, highlighting his contributions and advisory role. Earlier, in 2013, he was awarded the Outstanding Network Expert Token of Appreciation from SabaNet ISP for his expertise and dedication in the field of network services. Additionally, in 2007, he secured the Third Rank Token of Appreciation from Shiraz University of Technology, acknowledging his academic achievements during his undergraduate studies. These accolades reflect his commitment to both teaching and technical proficiency.

 Research Skills

Nima Darbandi possesses a diverse set of research skills, honed through extensive academic and professional experiences. His expertise includes optimizing the llama.cpp framework and developing AI systems for domain detection using DNS logs. He is proficient in various aspects of computer networks, evidenced by his teaching roles in Discrete Mathematics and Computer Networks. His background in Linux, cloud hosting, and virtualization (VMware VCenter) further strengthens his technical prowess. Additionally, Nima has practical experience with Network+, CCNA, and Linux Essentials, reflecting his broad knowledge in networking and system administration. His research contributions in artificial intelligence, particularly in early diagnosis and precision treatment of diseases, underscore his interdisciplinary approach and innovation in the field.

 

 

Jaydira Del Rivero | Medical Oncology | Best Researcher Award

Posted on by ScienceFather

Dr. Jaydira Del Rivero | Medical Oncology | Best Researcher Award

MD of NCI/NIH, United States.

Dr. Jaydira Del Rivero has a robust set of research skills tailored for oncology. Her expertise includes cell culture, immunohistochemistry, CRISPR/Cas9 gene editing, and advanced microscopy. Proficient in data analysis using SPSS and R, she excels in bioinformatics for genomic data. Dr. Del Rivero is adept at experimental design, critical literature evaluation, and communicating scientific results.

Professional Profiles:

Education

Dr. Jaydira Del Rivero earned her Doctor of Medicine (MD) degree from the University of Veracruz, Faculty of Medicine “Lic. Miguel Aleman Valdez” in October 2003. She completed her Internal Medicine residency at Woodhull Medical and Mental Health Center/NYU Langone Medical Center in Brooklyn, NY, from July 2008 to June 2011. Following this, she pursued a fellowship in Endocrinology, Diabetes, and Metabolism at the Inter-Institute Adult Endocrine Training Program at the National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, from July 2011 to June 2014. Dr. Del Rivero further specialized in Medical Oncology through a fellowship at the National Cancer Institute, National Institutes of Health, Bethesda, MD, from July 2015 to June 2017. Her extensive training reflects her deep commitment to advancing in both endocrinology and oncology.

Professional Experience

Dr. Jaydira Del Rivero has held several notable positions in the medical field. She began her career as a Medical Officer at the National Institute of Child Health and Human Development from August 2014 to June 2015, where she focused on endocrine research. Following her fellowship in Medical Oncology, she joined the National Cancer Institute (NCI) as a Clinical Fellow in the Medical Oncology Branch from July 2015 to June 2017. Since 2017, Dr. Del Rivero has been a Medical Oncologist at the NCI, specializing in the treatment and research of cancer. Her role involves clinical practice, patient management, and contributing to ongoing research efforts. Dr. Del Rivero’s work is pivotal in advancing the understanding and treatment of oncology-related conditions.

Research Interest

Dr. Jaydira Del Rivero’s research interests are centered around oncology, with a particular focus on advancing the understanding and treatment of cancer. Her work primarily explores endocrine-related malignancies, including the development of novel therapeutic strategies and treatment protocols. Dr. Del Rivero is involved in researching the mechanisms of cancer progression and resistance to treatments, aiming to improve patient outcomes through innovative approaches. Her research also encompasses the evaluation of new drugs and treatment regimens, with a commitment to integrating clinical findings with experimental data to enhance therapeutic efficacy. Through her work at the National Cancer Institute, she contributes to cutting-edge studies that aim to address critical challenges in cancer care and therapy.

Award and Honors

Dr. Jaydira Del Rivero has received several notable awards and honors for her contributions to oncology research. She was recognized with the prestigious NCI Director’s Award in 2021 for her exceptional work in cancer research and her commitment to advancing treatment options. In 2019, she earned the American Association for Cancer Research (AACR) Scholar Award, which acknowledged her innovative research on endocrine-related cancers. Additionally, Dr. Del Rivero was honored with the National Cancer Institute’s Outstanding Research Award in 2018 for her impactful studies on novel therapeutic strategies. Her achievements reflect her dedication to improving cancer care and her significant contributions to the field of oncology.

 Research Skills

Dr. Jaydira Del Rivero possesses advanced research skills essential for her work in oncology. She is proficient in various laboratory techniques including cell culture, immunohistochemistry, and molecular cloning. Her expertise extends to cutting-edge methods such as CRISPR/Cas9 gene editing and advanced microscopy techniques. Dr. Del Rivero is skilled in data analysis and statistical software such as SPSS and R, which she utilizes for interpreting complex research data. She also has experience with bioinformatics tools for genomic data analysis, enabling her to identify novel biomarkers and therapeutic targets. Her research skills are complemented by a strong ability to design and conduct experiments, critically evaluate scientific literature, and effectively communicate findings through publications and presentations.

Publications
  1. Sunitinib induces hypothyroidism in advanced cancer patients and may inhibit thyroid peroxidase activity
    Authors: E Wong, LS Rosen, M Mulay, A VanVugt, M Dinolfo, C Tomoda, …
    Journal: Thyroid
    Year: 2007
    Volume/Issue: 17 (4), 351-355
    Citations: 238
  2. The Bethesda handbook of clinical oncology
    Authors: J Abraham, JL Gulley
    Publisher: Lippincott Williams & Wilkins
    Year: 2022
    Citations: 158
  3. Anti–PD-L1 treatment induced central diabetes insipidus
    Authors: C Zhao, SH Tella, J Del Rivero, A Kommalapati, I Ebenuwa, J Gulley, …
    Journal: The Journal of Clinical Endocrinology & Metabolism
    Year: 2018
    Volume/Issue: 103 (2), 365-369
    Citations: 104
  4. Tyrosine kinase inhibitor–induced thyroid disorders: a review and hypothesis
    Authors: N Makita, T Iiri
    Journal: Thyroid
    Year: 2013
    Volume/Issue: 23 (2), 151-159
    Citations: 99
  5. Resection versus expectant management of small incidentally discovered nonfunctional pancreatic neuroendocrine tumors
    Authors: AM Rosenberg, P Friedmann, J Del Rivero, SK Libutti, AM Laird
    Journal: Surgery
    Year: 2016
    Volume/Issue: 159 (1), 302-310
    Citations: 93
  6. Phenotypic and genotypic characterization and treatment of a cohort with familial tumoral calcinosis/hyperostosis‐hyperphosphatemia syndrome
    Authors: MS Ramnitz, P Gourh, R Goldbach‐Mansky, F Wodajo, S Ichikawa, …
    Journal: Journal of Bone and Mineral Research
    Year: 2016
    Volume/Issue: 31 (10), 1845-1854
    Citations: 87
  7. The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and management of metastatic and/or unresectable pheochromocytoma and paraganglioma
    Authors: L Fishbein, J Del Rivero, T Else, JR Howe, SL Asa, DL Cohen, PLM Dahia, …
    Journal: Pancreas
    Year: 2021
    Volume/Issue: 50 (4), 469-493
    Citations: 77
  8. Novel insights into the polycythemia–paraganglioma–somatostatinoma syndrome
    Authors: R Därr, J Nambuba, J Del Rivero, I Janssen, M Merino, M Todorovic, …
    Journal: Endocrine-Related Cancer
    Year: 2016
    Volume/Issue: 23 (12), 899-908
    Citations: 76
  9. Endocrine‐related adverse events related to immune checkpoint inhibitors: Proposed algorithms for management
    Authors: J Del Rivero, LM Cordes, J Klubo‐Gwiezdzinska, RA Madan, LK Nieman, …
    Journal: The Oncologist
    Year: 2020
    Volume/Issue: 25 (4), 290-300
    Citations: 72
  10. Sunitinib (sutent)-induced thyrotoxicosis due to destructive thyroiditis: a case report
    Authors: JE Faris, AF Moore, GH Daniels
    Journal: Thyroid
    Year: 2007
    Volume/Issue: 17 (11), 1147-1149
    Citations: 72